Full Data
?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets
Join Now!
Need this critical market data?
Access thousands of market events, data points, and news articles!
Already have an account?
Login
Home » News » R&D investment of 14 million Huahai Pharmaceutical Roflumilast tablets approved in the United States